101 related articles for article (PubMed ID: 26253953)
1. Radiation-induced dose-dependent changes of the spleen following postoperative chemoradiotherapy for gastric cancer.
Trip AK; Sikorska K; van Sandick JW; Heeg M; Cats A; Boot H; Jansen EP; Verheij M
Radiother Oncol; 2015 Aug; 116(2):239-44. PubMed ID: 26253953
[TBL] [Abstract][Full Text] [Related]
2. IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer.
Trip AK; Nijkamp J; van Tinteren H; Cats A; Boot H; Jansen EP; Verheij M
Radiother Oncol; 2014 Aug; 112(2):289-94. PubMed ID: 25241995
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
Chakravarty T; Crane CH; Ajani JA; Mansfield PF; Briere TM; Beddar AS; Mok H; Reed VK; Krishnan S; Delclos ME; Das P
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):581-6. PubMed ID: 22137021
[TBL] [Abstract][Full Text] [Related]
4. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
Wang SL; Liao Z; Vaporciyan AA; Tucker SL; Liu H; Wei X; Swisher S; Ajani JA; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):692-9. PubMed ID: 16242257
[TBL] [Abstract][Full Text] [Related]
5. The relationship between splenic dose and radiation-induced lymphopenia.
Ma Y; Kong Y; Zhang S; Peng Y; Xu M; Zhang J; Xu H; Hong Z; Xing P; Qian J; Zhang L
J Radiat Res; 2024 May; 65(3):337-349. PubMed ID: 38718391
[TBL] [Abstract][Full Text] [Related]
6. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer.
Jansen EP; Saunders MP; Boot H; Oppedijk V; Dubbelman R; Porritt B; Cats A; Stroom J; Valdés Olmos R; Bartelink H; Verheij M
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):781-5. PubMed ID: 17157445
[TBL] [Abstract][Full Text] [Related]
7. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.
Kim HJ; Suh YG; Lee YC; Lee SK; Shin SK; Cho BC; Lee CG
Cancer Res Treat; 2017 Jul; 49(3):669-677. PubMed ID: 27737537
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.
Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH
Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507
[TBL] [Abstract][Full Text] [Related]
9. A pilot study for preoperative concurrent chemoradiotherapy with S-1 and cisplatin for locally advanced gastric cancer.
Chung MJ; Kim H; Jung YS; Shin SK; Hyung WJ; Noh SH; Seong J; Lee YC; Song SY
Hepatogastroenterology; 2013; 60(122):382-6. PubMed ID: 23858558
[TBL] [Abstract][Full Text] [Related]
10. [A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].
You J; Yu H; Song M; Shi C; Wang X; Zheng Y; Yu R; Shi A; Zhu G
Zhongguo Fei Ai Za Zhi; 2017 Jan; 20(1):28-34. PubMed ID: 28103970
[TBL] [Abstract][Full Text] [Related]
11. Long-term observations of radiation-induced creatinine clearance reduction and renal parenchymal volume atrophy.
Inaba K; Okamoto H; Wakita A; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Murakami N; Ito Y; Igaki H; Uno T; Itami J
Radiother Oncol; 2016 Jul; 120(1):145-9. PubMed ID: 27372224
[TBL] [Abstract][Full Text] [Related]
12. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
Park SH; Sohn TS; Lee J; Lim DH; Hong ME; Kim KM; Sohn I; Jung SH; Choi MG; Lee JH; Bae JM; Kim S; Kim ST; Park JO; Park YS; Lim HY; Kang WK
J Clin Oncol; 2015 Oct; 33(28):3130-6. PubMed ID: 25559811
[TBL] [Abstract][Full Text] [Related]
13. High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer.
Suh YG; Lee IJ; Koom WS; Cha J; Lee JY; Kim SK; Lee CG
Jpn J Clin Oncol; 2014 Jun; 44(6):534-40. PubMed ID: 24771865
[TBL] [Abstract][Full Text] [Related]
14. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer.
Jansen EP; Boot H; Saunders MP; Crosby TD; Dubbelman R; Bartelink H; Verheij M; Cats A
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1424-8. PubMed ID: 17689023
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of preoperative and postoperative chemoradiotherapy in gastric adenocarcinoma. Two phase II studies done in parallel. Fédération Francophone de Cancérologie Digestive 0308.
Michel P; Breysacher G; Mornex F; Seitz JF; Pere-Verge D; Martel-Lafay I; Faroux R; Chapet S; Sobhani I; Pezet D; Aparicio T; Nguyen S; Dousset B; Jouve JL; Maillard E
Eur J Cancer; 2014 Apr; 50(6):1076-83. PubMed ID: 24433843
[TBL] [Abstract][Full Text] [Related]
16. Postoperative chemoradiotherapy in gastric cancer -- a Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy.
Jansen EP; Boot H; Dubbelman R; Bartelink H; Cats A; Verheij M
Br J Cancer; 2007 Sep; 97(6):712-6. PubMed ID: 17848909
[TBL] [Abstract][Full Text] [Related]
17. Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation.
Franco P; Ragona R; Arcadipane F; Mistrangelo M; Cassoni P; Rondi N; Morino M; Racca P; Ricardi U
Med Oncol; 2016 Dec; 33(12):137. PubMed ID: 27815805
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
[TBL] [Abstract][Full Text] [Related]
19. Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.
Saito T; Toya R; Yoshida N; Shono T; Matsuyama T; Ninomura S; Watakabe T; Sasaki Y; Baba H; Oya N
In Vivo; 2018; 32(6):1519-1525. PubMed ID: 30348711
[TBL] [Abstract][Full Text] [Related]
20. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
